Irina Rivkind Koffler

Stock Analyst at Mizuho

(0)
# 3631
Out of 5,448 analysts
84
Total ratings
Success rate
Average return
16 Stocks
Name Action PT Current % Upside Ratings Updated
EOLS Evolus
Assumes: Buy
30
7.42 304.31% 4 Sep 5, 2019
AGN Allergan
Downgrades: Neutral
171 188
n/a n/a 8 Jun 26, 2019
DERM Journey Medical
Upgrades: Buy
17 14
7.08 97.74% 4 Jun 6, 2019
JAZZ Jazz Pharmaceuticals
Maintains: Neutral
146 148
120.53 22.79% 6 May 8, 2019
PCRX Pacira BioSciences
Upgrades: Neutral
29 38
25.39 49.67% 4 May 6, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
40 41
n/a n/a 7 Mar 22, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
11 5
n/a n/a 3 Mar 5, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
29 22
n/a n/a 3 Dec 17, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
61 63
43.32 45.43% 2 Dec 17, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
25 21
116.3 -81.94% 6 Nov 15, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
28 29
18.81 54.17% 7 Sep 17, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
n/a
n/a n/a 9 May 15, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
n/a
n/a n/a 3 May 2, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 7 Apr 4, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
17 0
n/a n/a 6 Dec 5, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 5 Oct 3, 2017